MiMedx Financial Statements From 2010 to 2025

MDXG Stock  USD 7.96  0.08  1.00%   
MiMedx financial statements provide useful quarterly and yearly information to potential MiMedx Group investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on MiMedx financial statements helps investors assess MiMedx's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting MiMedx's valuation are summarized below:
Gross Profit
288.8 M
Profit Margin
0.1216
Market Capitalization
1.2 B
Enterprise Value Revenue
3.1001
Revenue
348.9 M
There are over one hundred nineteen available fundamental ratios for MiMedx, which can be analyzed over time and compared to other ratios. Active traders should verify all of MiMedx last-minute fundamental drivers against the trend between 2010 and 2025 to make sure the company can sustain itself down the road. The MiMedx's current Market Cap is estimated to increase to about 1.5 B. The MiMedx's current Enterprise Value is estimated to increase to about 1.4 B

MiMedx Total Revenue

229.51 Million

Check MiMedx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MiMedx's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.8 M, Interest Expense of 1.8 M or Selling General Administrative of 129.7 M, as well as many indicators such as Price To Sales Ratio of 3.85, Dividend Yield of 0.0 or PTB Ratio of 6.96. MiMedx financial statements analysis is a perfect complement when working with MiMedx Valuation or Volatility modules.
  
Check out the analysis of MiMedx Correlation against competitors.

MiMedx Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets277.1 M263.9 M143.4 M
Slightly volatile
Short and Long Term Debt Total950 K1000 K41.4 M
Very volatile
Other Current Liabilities23.9 M37.2 M27.1 M
Slightly volatile
Total Current Liabilities31.6 M45.6 M36 M
Slightly volatile
Accounts Payable7.5 M7.4 M7.3 M
Slightly volatile
Cash109.6 M104.4 M51.7 M
Slightly volatile
Non Current Assets Total37.6 M72 M41.3 M
Slightly volatile
Non Currrent Assets Other666.9 K1.1 M690.9 K
Pretty Stable
Cash And Short Term Investments109.6 M104.4 M52.2 M
Slightly volatile
Common Stock Total Equity96.6 K101.7 K102 K
Slightly volatile
Common Stock Shares Outstanding98.3 M149 M103.2 M
Slightly volatile
Liabilities And Stockholders Equity277.1 M263.9 M143.4 M
Slightly volatile
Non Current Liabilities Total32 M25.2 M36.1 M
Slightly volatile
Other Current Assets4.3 M7.8 M4.9 M
Slightly volatile
Other Stockholder Equity298.4 M284.2 M154.5 M
Slightly volatile
Total Liabilities63.6 M70.8 M72.1 M
Slightly volatile
Total Current Assets201.5 M191.9 M99.8 M
Slightly volatile
Intangible Assets9.6 M11.6 M9.8 M
Pretty Stable
Common Stock102.8 K147 K105.7 K
Slightly volatile
Property Plant And Equipment Net8.5 M11.6 M9.7 M
Slightly volatile
Good Will12.4 M22.4 M13.5 M
Slightly volatile
Property Plant And Equipment Gross34.5 M32.9 M13.9 M
Slightly volatile
Short Term Debt1.3 M1000 K1.3 M
Slightly volatile
Net Receivables28.5 M55.8 M27.7 M
Slightly volatile
Inventory25 M23.8 M11.5 M
Slightly volatile
Other Liabilities2.6 M2.1 M3.2 M
Pretty Stable
Long Term Debt Total74.8 M71.2 M52.3 M
Slightly volatile
Capital Surpluse157.7 M190.5 M147 M
Slightly volatile
Property Plant Equipment10.9 M12.9 M9.7 M
Slightly volatile
Long Term Investments2.6 M2.9 M3.2 M
Slightly volatile
Short and Long Term Debt1.6 M1.1 M1.1 M
Slightly volatile
Non Current Liabilities Other4.8 M7.4 M6.3 M
Slightly volatile
Net Invested Capital222.5 M211.9 M93.2 M
Slightly volatile
Net Working Capital85.8 M146.3 M45.7 M
Slightly volatile
Capital Stock139.7 K147 K11.6 M
Pretty Stable
Warrants101.2 M106.4 M93.3 M
Slightly volatile

MiMedx Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization3.8 MM4.2 M
Slightly volatile
Selling General Administrative129.7 M225.1 M146.4 M
Slightly volatile
Other Operating Expenses177.3 M290 M200.6 M
Slightly volatile
Research Development10.2 M12.3 M10.9 M
Slightly volatile
Total Operating Expenses151.9 M229.9 M171.8 M
Slightly volatile
Total Revenue229.5 M348.9 M210 M
Slightly volatile
Cost Of Revenue32.1 M60.1 M29.4 M
Slightly volatile
Reconciled Depreciation4.6 MM5.7 M
Slightly volatile
Non Recurring45.3 K47.7 K358.7 K
Slightly volatile

MiMedx Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation3.8 MM4.1 M
Slightly volatile
Capital Expenditures1.6 M1.7 M3.7 M
Very volatile
End Period Cash Flow109.6 M104.4 M50 M
Slightly volatile
Begin Period Cash Flow86.1 M82 M42.4 M
Slightly volatile
Stock Based Compensation12.3 M16.9 M12.1 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.854.052811.4577
Slightly volatile
Days Sales Outstanding73.1558.407766.9196
Slightly volatile
Average Payables1.4 M2.8 M2.5 M
Slightly volatile
Stock Based Compensation To Revenue0.04610.04850.1629
Slightly volatile
Capex To Depreciation0.260.27860.9841
Slightly volatile
EV To Sales3.573.756411.2051
Slightly volatile
Inventory Turnover4.262.52333.8958
Slightly volatile
Days Of Inventory On Hand99.54145123
Very volatile
Payables Turnover8.518.10814.4792
Slightly volatile
Research And Ddevelopement To Revenue0.03360.03540.2883
Slightly volatile
Capex To Revenue0.00460.00480.033
Slightly volatile
Cash Per Share0.750.71040.5396
Slightly volatile
Days Payables Outstanding42.7745.016697.3155
Slightly volatile
Intangibles To Total Assets0.110.11770.2279
Slightly volatile
Current Ratio4.614.20853.4328
Pretty Stable
Receivables Turnover5.946.249284.6031
Very volatile
Graham Number2.052.92092.6015
Slightly volatile
Capex Per Share0.01090.01150.0444
Slightly volatile
Average Receivables11.2 M10.7 M10.4 M
Slightly volatile
Revenue Per Share1.472.37371.8189
Slightly volatile
Interest Debt Per Share0.0130.01360.1743
Slightly volatile
Debt To Assets0.00360.00380.1481
Pretty Stable
Operating Cycle210203192
Pretty Stable
Days Of Payables Outstanding42.7745.016697.3155
Slightly volatile
Ebt Per Ebit0.910.97331.1449
Very volatile
Long Term Debt To Capitalization0.220.230.6187
Pretty Stable
Total Debt To Capitalization0.00490.00520.3559
Pretty Stable
Quick Ratio4.363.68633.1491
Pretty Stable
Net Income Per E B T0.70.74041.5369
Very volatile
Cash Ratio2.632.29011.9985
Pretty Stable
Days Of Inventory Outstanding99.54145123
Very volatile
Days Of Sales Outstanding73.1558.407766.9196
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.870.97461.7926
Pretty Stable
Fixed Asset Turnover15.7830.20619.4749
Slightly volatile
Debt Ratio0.00360.00380.1481
Pretty Stable
Price Sales Ratio3.854.052811.4577
Slightly volatile
Asset Turnover1.061.32191.3028
Slightly volatile

MiMedx Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.5 B1.4 B790.7 M
Slightly volatile

MiMedx Fundamental Market Drivers

Forward Price Earnings19.5313
Cash And Short Term Investments104.4 M

MiMedx Upcoming Events

27th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About MiMedx Financial Statements

MiMedx stakeholders use historical fundamental indicators, such as MiMedx's revenue or net income, to determine how well the company is positioned to perform in the future. Although MiMedx investors may analyze each financial statement separately, they are all interrelated. For example, changes in MiMedx's assets and liabilities are reflected in the revenues and expenses on MiMedx's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in MiMedx Group. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue-1.4 M-1.5 M
Total Revenue348.9 M229.5 M
Cost Of Revenue60.1 M32.1 M
Stock Based Compensation To Revenue 0.05  0.05 
Research And Ddevelopement To Revenue 0.04  0.03 
Revenue Per Share 2.37  1.47 
Ebit Per Revenue 0.17  0.18 

Currently Active Assets on Macroaxis

When determining whether MiMedx Group is a strong investment it is important to analyze MiMedx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MiMedx's future performance. For an informed investment choice regarding MiMedx Stock, refer to the following important reports:
Check out the analysis of MiMedx Correlation against competitors.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MiMedx. If investors know MiMedx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MiMedx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.86)
Earnings Share
0.28
Revenue Per Share
2.374
Quarterly Revenue Growth
0.07
Return On Assets
0.1474
The market value of MiMedx Group is measured differently than its book value, which is the value of MiMedx that is recorded on the company's balance sheet. Investors also form their own opinion of MiMedx's value that differs from its market value or its book value, called intrinsic value, which is MiMedx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MiMedx's market value can be influenced by many factors that don't directly affect MiMedx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MiMedx's value and its price as these two are different measures arrived at by different means. Investors typically determine if MiMedx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MiMedx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.